@incollection{,
	
					
					
					30AF2E26F26B04789CECC224E3FAF090
				,
	author={{haramasa} and {Nagoya City University}},
	journal={{Global Journal of Medical Research}},
	journal={{GJMR}}2249-46180975-588810.34257/GJMR,
	address={Cambridge, United States},
	publisher={Global Journals Organisation}13315
}

@incollection{b0,
	
	
		,
	title={{TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy}}
		,
	author={{
			HLu
		}}
	
	
		,
	journal={{Clinical cancer research : an official journal of the American Association for Cancer Research}}
		
			17
			
			,
	year={2011}
		
	

}

@incollection{b1,
	
	
		,
	title={{Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer: a randomised controlled study}}
		,
	author={{
			SOhwada
		}}
	
	
		,
	journal={{British journal of cancer}}
		
			90
			
			,
	year={2004}
		
	

}

@incollection{b2,
	
	
		,
	title={{Long-term effect of 5-fluorouracil enhanced by intermittent administration of polysaccharide K after curative resection of colon cancer. A randomized controlled trial for 7-year follow-up}}
		,
	author={{
			KIto
		}}
	
	
		,
	journal={{International journal of colorectal disease}}
		
			19
			
			,
	year={2004}
		
	

}

@incollection{b3,
	
	
		,
	title={{Adjuvant therapy with proteinbound polysaccharide K and tegafur uracil in patients with stage II or III colorectal cancer: randomized, controlled trial}}
		,
	author={{
			SOhwada
		}}
	
	
		,
	journal={{Diseases of the colon and rectum}}
		
			46
			
			,
	year={2003}
		
	

}

@incollection{b4,
	
	
		,
	title={{A phase III trial of FOLFIRI or FOLFOX with bevacizumab or cetuximab or both for untreated metastatic adenocarcinoma of the colon or rectum}}
		,
	author={{
			Calgb/Swog C80405
		}}
	
	
		,
	journal={{Clinical advances in hematology & oncology : H&O}}
		
			4
			
			,
	year={2006}
		
	

}

@incollection{b5,
	
	
		,
	title={{Second-line chemotherapy use in metastatic colon cancer varies by disease responsiveness}}
		,
	author={{
			SPolitano
		}}
	
	
		,
	journal={{Clinical colorectal cancer}}
		
			7
			
			,
	year={2008}
		
	

}

@incollection{b6,
	
	
		,
	title={{Cetuximab plus oxaliplatin-based chemotherapy in the treatment of colorectal cancer}}
		,
	author={{
			NMoosmann
		} and {
			VHeinemann
		}}
		
	
	
		,
	journal={{Expert review of anticancer therapy}}
		
			8
			
			,
	year={2008}
		
	

}

@incollection{b7,
	
	
		,
	title={{First-and second-line therapy of metastatic colorectal cancer}}
		,
	author={{
			STerstriep
		} and {
			AGrothey
		}}
		
	
	
		,
	journal={{Expert review of anticancer therapy}}
		
			6
			
			,
	year={2006}
		
	

}

@incollection{b8,
	
	
		,
	title={{Successful desensitization with cetuximab after an infusion reaction to panitumumab in patients with metastatic colorectal cancer}}
		,
	author={{
			MWSaif
		}}
	
	
		,
	journal={{Cancer and pharmacology}}
		
			65
			
			,
	year={2009}
		
	

}

@incollection{b9,
	
	
		,
	title={{Successful rechallenge with panitumumab in patients who developed hypersensitivity reactions to cetuximab: report of three cases and review of literature}}
		,
	author={{
			MWSaif
		} and {
			JPeccerillo
		} and {
			VPotter
		}}
		
		
	
	
		,
	journal={{Cancer chemotherapy and pharmacology}}
		
			63
			
			,
	year={2009}
		
	

}

@incollection{b10,
	
	
		,
	title={{Challenges in the use of epidermal growth factor receptor inhibitors in colorectal cancer}}
		,
	author={{
			EVan Cutsem
		}}
	
	
		,
	journal={{The oncologist}}
		
			11
			
			,
	year={2006}
		
	

}

@incollection{b11,
	
	
		,
	title={{Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicity}}
		,
	author={{
			MHara
		}}
	
	
		,
	journal={{Cancer science}}
		
			99
			
			,
	year={2008}
		
	

}

@incollection{b12,
	
	
		,
	title={{Polysaccharide-K (PSK) increases p21(WAF/Cip1) and promotes apoptosis in pancreatic cancer cells}}
		,
	author={{
			AHRosendahl
		} and {
			CSun
		} and {
			DWu
		} and {
			RAndersson
		}}
		
		
		
	
	
		,
	journal={{Pancreatology}}
		
			12
			
			,
	year={2012}
		
	

}

@incollection{b13,
	
	
		,
	title={{The status of EGFR-associated genes could predict the outcome and tumor response of chemo-refractory metastatic colorectal patients using cetuximab and chemotherapy}}
		,
	author={{
			JKLin
		}}
	
	
		,
	journal={{Journal of surgical oncology}}
		
			104
			
			,
	year={2011}
		
	

}